NKTX (STOCKS)
Nkarta, Inc. Common Stock
$2.740000
-0.120000 (-4.20%)
Prev close: $2.860000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Paul J. Hastings
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $195.32M
- Employees
- 157
- P/E (TTM)
- -2.03
- P/B (TTM)
- 0.71
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.37 | $-0.38 | +0.0100 | +2.63% |
|
Dec 2025 (Q4)
|
$-0.37 | $-0.32 | -0.0456 | -14.06% |
|
Sep 2025 (Q3)
|
$-0.29 | $-0.32 | +0.0296 | +9.26% |
|
Jun 2025 (Q2)
|
$-0.31 | $-0.36 | +0.0521 | +14.39% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $16.38M |
| Operating Expenses | $116.31M |
| Depreciation and Amortization | $9.23M |
| Research and Development | $91.25M |
| Other Operating Expenses | $15.83M |
| Operating Income/Loss | -$116.31M |
| Income/Loss From Continuing Operations After Tax | -$99.93M |
| Income/Loss From Continuing Operations Before Tax | -$99.93M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$99.93M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$99.93M |
| Net Income/Loss Available To Common Stockholders, Basic | -$99.93M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.34 |
| Diluted Earnings Per Share | -$1.34 |
| Basic Average Shares | 222,278,060 |
| Diluted Average Shares | 222,278,060 |
| Assets | $372.07M |
| Current Assets | $235.89M |
| Noncurrent Assets | $136.19M |
| Fixed Assets | $64.42M |
| Other Non-current Assets | $71.77M |
| Liabilities | $86.21M |
| Current Liabilities | $18.21M |
| Accounts Payable | $1.59M |
| Wages | $2.98M |
| Other Current Liabilities | $13.64M |
| Noncurrent Liabilities | $68.01M |
| Equity | $285.86M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $285.86M |
| Liabilities And Equity | $372.07M |
| Net Cash Flow From Operating Activities | -$87.29M |
| Net Cash Flow From Operating Activities, Continuing | -$87.29M |
| Net Cash Flow From Investing Activities | $61.90M |
| Net Cash Flow From Investing Activities, Continuing | $61.90M |
| Net Cash Flow From Financing Activities | $24.87M |
| Net Cash Flow From Financing Activities, Continuing | $24.87M |
| Net Cash Flow | -$517.00K |
| Net Cash Flow, Continuing | -$517.00K |
| Comprehensive Income/Loss | -$100.43M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$100.72M |
| Other Comprehensive Income/Loss | -$22.21M |